Reentry Incentives and Support for Engagement With Contingency Management
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention.
- Who it may be relevant to
- Registry conditions: Opioid Use Disorder. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Enhancing Medication for Opioid Use Disorder Retention With Post-Release Contingency Management
Overview
People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community. In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions. Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD. The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.
Interventions
- Other Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention
Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration.
Primary outcome measures
- Number of patients receiving medication for opioid use disorder [Time frame: 1, 2, and 3 months]
Secondary outcome measures (4)
- Number of contingency management sessions attended [Time frame: 3 months]
- Total contingency management rewards earned [Time frame: 3 months]
- Addiction Severity [Time frame: Baseline and 3 months]
- Recovery Capital [Time frame: Baseline and 3 months]
Eligibility criteria
Inclusion criteria
- Be adults (age ≥18 years) currently incarcerated at Clatsop County Jail
- Be enrolled in the jail's MOUD program at the time of recruitment
- Plan to continue MOUD with Clatsop Behavioral Healthcare upon release
- Speak English and be able to provide informed consent
Exclusion criteria
Exclusion criteria
- Are unable to provide informed consent due to cognitive impairment or acute psychiatric instability
- Are scheduled for transfer to a different facility or geographic location that prevents post-release participation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Clatsop County Corrections — Warrenton
Identifiers
NCT: NCT07322588 · STUDY00028902 · Agreement #184714